Supreme Court May Be Partly to Blame for Shortage of At-Home Rapid COVID-19 Tests During Pandemic

Apr 25, 2022 | Compliance, Legal, and Malpractice, Laboratory News, Laboratory Pathology, Laboratory Resources, Laboratory Testing, Precision Medicine

High court decision in 2012 altered patent law and effectively blocked protections for certain clinical laboratory diagnostic tests and procedures Clinical laboratory leaders and pathologists will be interested to learn that a US Supreme Court (SCOTUS) decision from 2012 may be partly to blame for the shortage of at-home COVID-19 rapid antigen tests while the SARS-CoV-2 Omicron variant surged this past winter. During that time, consumer demand for all COVID-19 at-home tests quickly depleted...

Federal Appeals Court Hears Arguments in the Myriad Genetics’ Gene Patent Case

Apr 22, 2011 | Laboratory Pathology, News From Dark Daily

At issue is ability of biotech companies to hold patents on genes that might be used in clinical laboratory testing Patents involving human genes have always been controversial among pathologists and clinical laboratory managers. This is one reason why many in the medical laboratory testing industry are following the progress of the well-publicized lawsuit that challenged certain patents involving human genes that are held by Myriad Genetics, Inc. (Myriad), of Salt Lake City, Utah. In the...
;